Studies indicate that schizophrenia and bipolar disorder patients exhibit higher fasting blood glucose (FBS), glycated hemoglobin (HbA1c), lipid abnormalities, and increased inflammatory markers such as C-reactive protein (CRP), which may contribute to an elevated risk of cardiovascular disease (CVD) and metabolic syndrome [4]. The gene discussed is CRP; the disease is bipolar disorder.